Perrigo (PRGO) Deferred Taxes (2013 - 2026)
Perrigo's (PRGO) quarterly Deferred Taxes came in at -$12.9 million in Q1 2026, down 316.13% year-on-year from $6.0 million in Q1 2025, and up 64.95% on a QoQ basis from -$36.8 million in Q4 2025.
Perrigo (PRGO) Deferred Taxes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Deferred Taxes data on file, last reported at -$12.9 million in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 316.13% year-over-year to -$12.9 million in Q1 2026; TTM through Mar 2026 was -$60.6 million, a 442.37% decrease from a year earlier, with the FY2025 full-year figure at -$50.8 million, down 618.37% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$12.9 million, up from -$36.8 million in the prior quarter.
- Over the last five years, Deferred Taxes for PRGO reached as high as $23.3 million in Q4 2024 and fell as low as -$118.9 million in Q4 2023.
- Historically, Deferred Taxes has averaged -$12.4 million across 5 years, with a median of -$9.9 million in 2023.
- On a YoY basis, Deferred Taxes climbed as much as 314.29% in 2022 and fell as far as 2400.0% in 2022.
- Year by year, Deferred Taxes stood at -$30.9 million in 2022, then tumbled by 284.79% to -$118.9 million in 2023, then jumped by 119.6% to $23.3 million in 2024, then plunged by 257.94% to -$36.8 million in 2025, then soared by 64.95% to -$12.9 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$12.9 million in Q1 2026, -$36.8 million in Q4 2025, and -$23.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -12.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -12.90 Mn |
| Dec 31, 2025 | -36.80 Mn |
| Sep 27, 2025 | -23.60 Mn |
| Jun 28, 2025 | 12.70 Mn |
| Mar 29, 2025 | -3.10 Mn |
| Dec 31, 2024 | 23.30 Mn |
| Sep 28, 2024 | -14.80 Mn |
| Jun 29, 2024 | 12.30 Mn |
| Mar 30, 2024 | -11.00 Mn |
| Dec 31, 2023 | -118.90 Mn |
| Sep 30, 2023 | 14.10 Mn |
| Jul 1, 2023 | 8.10 Mn |
| Apr 1, 2023 | -9.90 Mn |
| Dec 31, 2022 | -30.90 Mn |
| Oct 1, 2022 | -32.20 Mn |
| Jul 2, 2022 | 7.50 Mn |
| Apr 2, 2022 | 5.10 Mn |
| Dec 31, 2021 | 33.40 Mn |
| Oct 2, 2021 | 1.40 Mn |
| Jul 3, 2021 | -3.50 Mn |